Timaran David E, Knowles Martyn, Soto-Gonzalez Marilisa, Modrall J Gregory, Tsai Shirling, Kirkwood Melissa, Rectenwald John, Timaran Carlos H
Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Tex.
Division of Vascular Surgery, University of North Carolina-Health Care, Chapel Hill, NC.
J Vasc Surg. 2016 Aug;64(2):267-272. doi: 10.1016/j.jvs.2016.02.062. Epub 2016 Jun 15.
The role of gender on perioperative outcomes after fenestrated endovascular aortic aneurysm repair (FEVAR) has not been established. The aim of this study is to determine the effect of gender on perioperative outcomes after FEVAR for complex abdominal aortic aneurysms using premanufactured devices.
During a 2-year period, 79 patients (63 men [80%] and 16 women [20%]) underwent FEVAR using Zenith Fenestrated AAA Endovascular Grafts, investigational Zenith pivot branch (p-branch) devices and fenestrated custom-made devices. A single-institutional study was performed to evaluate postoperative outcomes after FEVAR. The χ, Fisher's, and nonparametric tests were used for bivariate analysis. Logistic regression was used for multivariate analysis.
Median age was 73 years (interquartile range [IQR], 68-79 years). The median number of fenestrations was three. There was no difference in aneurysm anatomic location, size, or number of fenestrations between patients in either group. Women were more likely to undergo endoconduits at the access site before the target procedure (19% vs 2%; P = .02). The overall postoperative complication rate was similar among females and males (31% vs 33%; P > .5). However, women experienced longer times in the intensive care unit (median, 3 days [IQR, 2-5] vs 2 [IQR, 1-3]; P = .05) and longer duration of hospital stay (median, 4.5 days [IQR, 3-6.5] vs 3 [IQR, 2-4]; P < .01). Similarly, the rate of reinterventions was higher among women, 25% vs 5% (P = .02). For renal adverse events, there was a trend for a higher rate of renal function deterioration based in creatinine levels among women, when compared with men (18% vs 5%; P = .09). Multivariate analysis showed that female gender was associated with a 8-fold increased risk of renal function deterioration (odds ratio, 8.1; 95% confidence interval, 6.1-10.8). Female gender was also identified as in independent factor for reinterventions at 30 days (odds ratio, 7.4; 95% confidence interval, 6.7-8.1).
FEVAR is a safe and effective procedure for patients at high and standard risk for open repair who are not eligible for standard EVAR. Women are at greater risk for more severe renal function deterioration, early reinterventions and longer durations of hospital and intensive care unit stay.
开窗式血管腔内主动脉瘤修复术(FEVAR)围手术期结局的性别差异尚未明确。本研究旨在使用预制装置,确定性别对复杂腹主动脉瘤FEVAR围手术期结局的影响。
在两年期间,79例患者(63例男性[80%]和16例女性[20%])接受了使用Zenith开窗式腹主动脉瘤血管腔内移植物、试验性Zenith枢轴分支(p-分支)装置和定制开窗式装置的FEVAR。进行了一项单中心研究,以评估FEVAR术后结局。采用卡方检验、Fisher检验和非参数检验进行双变量分析。采用逻辑回归进行多变量分析。
中位年龄为73岁(四分位间距[IQR],68-79岁)。开窗的中位数量为3个。两组患者的动脉瘤解剖位置、大小或开窗数量无差异。女性在目标手术前更有可能在入路部位进行内置导管操作(19%对2%;P = 0.02)。女性和男性的总体术后并发症发生率相似(31%对33%;P > 0.5)。然而,女性在重症监护病房的时间更长(中位时间,3天[IQR,2-5]对2天[IQR,1-3];P = 0.05),住院时间也更长(中位时间,4.5天[IQR,3-6.5]对3天[IQR,2-4];P < 0.01)。同样,女性的再次干预率更高,为25%对5%(P = 0.02)。对于肾脏不良事件,与男性相比,女性基于肌酐水平的肾功能恶化率有升高趋势(18%对5%;P = 0.09)。多变量分析显示,女性性别与肾功能恶化风险增加8倍相关(比值比,8.1;95%置信区间,6.1-10.8)。女性性别也被确定为30天再次干预的独立因素(比值比,7.4;95%置信区间,6.7-8.1)。
对于不适合标准血管腔内修复术且具有高风险和标准风险的开放修复患者,FEVAR是一种安全有效的手术。女性发生更严重肾功能恶化、早期再次干预以及住院和重症监护病房停留时间更长的风险更高。